Antibody-Drug Conjugation at ChemPartner
ChemPartner has a top-tier Antibody-Drug Conjugation (ADC) team spanning multiple areas, including antibody development, design and synthesis of linker and payload, conjugation chemistry, as well as ADC analytical, efficacy, toxicology, and DMPK studies. Using state-of-the-art technologies, our scientists have been helping numerous clients design novel ADCs and solve technical challenges in their ADC development processes. Please click on the following posters for more details.